Chimerix Inc (CMRX)
US$ 8.550.12%
Price Chart
Key Statistics
Market Cap
$ 801.08M
P/E Ratio
0.00
Revenue (TTM)
$ 212K
Volume
1.58M
52W High
$ 8.55
52W Low
$ 0.75
Dividend Yield
0.00%
Beta
-0.18
Technicals
50-Day MA
7.3076
200-Day MA
3.0893
52 Week High
8.55
52 Week Low
0.75
About CMRX
Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases in the United States.
Employees
79
Headquarters
Durham, NC
CEO
Mr. Michael T. Andriole M.B.A.
Latest News
Jazz To Buy Chimerix For $935 Mln To Boost Oncology Portfolio, CMRX Up In Pre-Market - Nasdaq
2025-03-05 • Google News
Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? - Yahoo Finance
2025-04-01 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg